SCID stands for “Severe Combined Immunodeficiency.” It is a rare and serious genetic disorder that affects the immune system’s ability to defend the body against infections. SCID is often referred to as the “bubble boy disease” due to the famous case of David Vetter, a child with SCID who lived in a sterile plastic bubble to protect him from infections.
Individuals with SCID have a severely compromised immune system, making them extremely susceptible to various infections, including bacterial, viral, and fungal diseases. The condition is typically caused by genetic mutations that affect the development and function of immune cells, particularly T cells and B cells, which are essential components of the immune system.
SCID can manifest early in life, often in infancy, with affected individuals experiencing recurrent and life-threatening infections. Without intervention, SCID is often fatal.
Treatment for SCID typically involves hematopoietic stem cell transplantation (HSCT), which can provide a source of healthy immune cells to replace the defective ones. Gene therapy is another emerging treatment option for some forms of SCID. Additionally, individuals with SCID may require lifelong medical management and precautions to reduce the risk of infections.
Early diagnosis and intervention are critical for improving the prognosis of individuals with SCID. Newborn screening programs in some countries have helped identify SCID cases in the early stages, allowing for timely treatment and improved outcomes.